Copyright: ©Author(s) 2026.
World J Gastroenterol. Nov 28, 2026; 32(44): 122876
Published online Nov 28, 2026. doi: 10.3748/wjg.122876
Published online Nov 28, 2026. doi: 10.3748/wjg.122876
Table 5 Summary of adverse events during treatment, n (%)
| AEs | FM + LPZ (n = 82) | P + LPZ (n = 82) |
| Patients with AEs | 4 (4.9) | 2 (2.4) |
| Constipation | 2 (2.4) | 0 (0) |
| Nausea | 0 (0) | 1 (1.2) |
| Sleep disturbance | 1 (1.2) | 1 (1.2) |
| Increased heart rate | 1 (1.2) | 0 (0) |
- Citation: Yin KH, Wang XY, Wang XY, Cheng L, Wang B, Wang QQ, Qiao Y, Tang XR, Yan XJ, Chen SL. Efficacy and safety of neuromodulators combined with proton pump inhibitors for non-erosive reflux disease: A randomized clinical trial. World J Gastroenterol 2026; 32(44): 122876
- URL: https://www.wjgnet.com/1007-9327/full/v32/i44/122876.htm
- DOI: https://dx.doi.org/10.3748/wjg.122876